🔴 ADMA Biologics is trading 4.4% down today with no clear catalyst identified

ADMA Biologics is trading at $8.40 (4.4% down) in after-hours trading with no clear catalyst identified for the move.

• The decline follows a recent multi-day upswing, suggesting the move may be a technical pullback or profit-taking rather than a fundamental shift.
• No company-specific news, earnings reports, FDA updates, or analyst actions have surfaced to explain the downward pressure.
• The price action may be exacerbated by typical after-hours market conditions, including thinner liquidity and wider bid-ask spreads.